全文获取类型
收费全文 | 161692篇 |
免费 | 32508篇 |
国内免费 | 2454篇 |
专业分类
耳鼻咽喉 | 5283篇 |
儿科学 | 5620篇 |
妇产科学 | 2486篇 |
基础医学 | 4517篇 |
口腔科学 | 1769篇 |
临床医学 | 27180篇 |
内科学 | 49905篇 |
皮肤病学 | 7596篇 |
神经病学 | 15725篇 |
特种医学 | 6839篇 |
外科学 | 43176篇 |
综合类 | 314篇 |
现状与发展 | 72篇 |
预防医学 | 7317篇 |
眼科学 | 3775篇 |
药学 | 1952篇 |
中国医学 | 89篇 |
肿瘤学 | 13039篇 |
出版年
2024年 | 686篇 |
2023年 | 4814篇 |
2022年 | 1256篇 |
2021年 | 3198篇 |
2020年 | 6100篇 |
2019年 | 2244篇 |
2018年 | 7501篇 |
2017年 | 7425篇 |
2016年 | 8550篇 |
2015年 | 8560篇 |
2014年 | 15661篇 |
2013年 | 15923篇 |
2012年 | 6017篇 |
2011年 | 6103篇 |
2010年 | 10652篇 |
2009年 | 14517篇 |
2008年 | 6418篇 |
2007年 | 4792篇 |
2006年 | 7281篇 |
2005年 | 4613篇 |
2004年 | 3918篇 |
2003年 | 2850篇 |
2002年 | 2973篇 |
2001年 | 4004篇 |
2000年 | 3170篇 |
1999年 | 3422篇 |
1998年 | 3884篇 |
1997年 | 3672篇 |
1996年 | 3548篇 |
1995年 | 3364篇 |
1994年 | 2113篇 |
1993年 | 1698篇 |
1992年 | 1521篇 |
1991年 | 1544篇 |
1990年 | 1187篇 |
1989年 | 1283篇 |
1988年 | 1115篇 |
1987年 | 940篇 |
1986年 | 977篇 |
1985年 | 810篇 |
1984年 | 635篇 |
1983年 | 589篇 |
1982年 | 592篇 |
1981年 | 462篇 |
1980年 | 426篇 |
1979年 | 362篇 |
1978年 | 386篇 |
1977年 | 444篇 |
1975年 | 307篇 |
1972年 | 322篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
75.
76.
Shinichiro Uchiyama Takao Hoshino Leila Sissani Monteiro Tavares Linsay Kenji Kamiyama Taizen Nakase Kazuo Kitagawa Kazuo Minematsu Kenichi Todo Yasushi Okada Jyoji Nakagawara Ken Nagata Hiroshi Yamagami Takenori Yamaguchi Pierre Amarenco 《Journal of stroke and cerebrovascular diseases》2019,28(8):2232-2241
BackgroundTIAregistry.org is an international cohort of patients with transient ischemic attack (TIA) or minor stroke within 7 days before enrollment in the registry. Main analyses of 1-year follow-up data have been reported.5 We conducted subanalysis on the baseline and 1-year follow-up data of Japanese patients.MethodsThe patients were classified into 2 groups based on Japanese ethnicity, Japanese (345) and non-Japanese (3238), and their baseline data and 1-year event rates were compared. We also determined risk factors and predictors of 1-year stroke.ResultsCurrent smoking, regular alcohol drinking, intracranial arterial stenosis, and small vessel occlusion; and hypertension, dyslipidemia, coronary artery disease, and extracranial arterial stenosis were more and less common among Japanese patients, respectively. Stroke risk was higher and TIA risk was lower at 1-year follow-up among Japanese patients. The baseline risk factors for recurrent stroke were diabetes, alcohol drinking, and large artery atherosclerosis. Independent predictors of 1-year stroke risk were prior congestive heart failure and alcohol consumption.ConclusionsThe two populations of patients featured differences in risk factors, stroke subtypes, and outcome events. Predictors of recurrent stroke among Japanese patients included congestive heart failure and regular alcohol drinking. Strategies to attenuate residual risk of stroke aside from adherence to current guidelines should take our Japanese-patient specific findings into account. 相似文献
77.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
78.
79.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
80.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310